Your browser doesn't support javascript.
loading
An evidence-based review of neuromodulation for the treatment and management of refractory angina.
Urits, Ivan; Patel, Anjana; Leider, Joseph; Anya, Anthony; Franscioni, Henry; Jung, Jai Won; Kassem, Hisham; Kaye, Alan D; Viswanath, Omar.
Afiliación
  • Urits I; Beth Israel Deaconess Medical Center, Department of Anesthesia, Critical Care, and Pain Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: ivanurits@gmail.com.
  • Patel A; Georgetown University School of Medicine, Washington, DC, USA.
  • Leider J; Georgetown University School of Medicine, Washington, DC, USA.
  • Anya A; Georgetown University School of Medicine, Washington, DC, USA.
  • Franscioni H; Georgetown University School of Medicine, Washington, DC, USA.
  • Jung JW; Georgetown University School of Medicine, Washington, DC, USA.
  • Kassem H; Mount Sinai Medical Center, Department of Anesthesiology, Miami Beach, FL, USA.
  • Kaye AD; Louisiana State University Health Shreveport, Department of Anesthesiology, Shreveport, LA, USA.
  • Viswanath O; Louisiana State University Health Shreveport, Department of Anesthesiology, Shreveport, LA, USA; Valley Pain Consultants - Envision Physician Services, Phoenix, AZ, USA; Creighton University School of Medicine, Department of Anesthesiology, Omaha, NE, USA; University of Arizona College of Medicine-P
Best Pract Res Clin Anaesthesiol ; 34(3): 517-528, 2020 Sep.
Article en En | MEDLINE | ID: mdl-33004163
Angina pectoris is defined as substernal chest pain that is typically exacerbated by exertion, stress, or other exposures. There are various methods of treatment for angina. Lifestyle modification and pharmacological management are considered as conservative treatments. If these medications do not result in the resolution of pain, more invasive approaches are an option, like coronary revascularization. Refractory angina (RA) is differentiated from acute or chronic angina based on the persistence of symptoms despite conventional therapies. Overall, the prevalence of RA is estimated to be 5%-15% in patients with coronary artery disease, which can account for up to 1,500,000 current cases and 100,000 new cases in the United States per year. Spinal cord stimulation treatment is a viable option for patients who are suffering from RA pain and are either not candidates for revascularization surgery or are currently not being well managed on more traditional treatments. Many studies show a positive result.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Dolor Intratable / Estimulación Eléctrica Transcutánea del Nervio / Medicina Basada en la Evidencia / Manejo del Dolor / Estimulación de la Médula Espinal / Angina de Pecho Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Best Pract Res Clin Anaesthesiol Asunto de la revista: ANESTESIOLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Dolor Intratable / Estimulación Eléctrica Transcutánea del Nervio / Medicina Basada en la Evidencia / Manejo del Dolor / Estimulación de la Médula Espinal / Angina de Pecho Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Best Pract Res Clin Anaesthesiol Asunto de la revista: ANESTESIOLOGIA Año: 2020 Tipo del documento: Article
...